Abstract: The present invention relates to novel 3-(2-chlor-4-trifluoromethylphenoxy)-1-azetidine carboxamides having the formula: ##STR1## wherein R1 and R2, same or different, are selected from hydrogen, C.sub.1 -C.sub.4 alkyl, and allyl.In a series of 3-(substitutedphenoxy)-1-azetidinecarboxamides, introduction of a chlorine atom at the 2-position of the phenoxy group of the corresponding 4-trifluoromethylphenoxy-1-azetidinecarboxamides resulted in unexpected increased potency in anticonvulsant pharmacological tests.
Type:
Grant
Filed:
December 7, 1990
Date of Patent:
March 10, 1992
Assignee:
A. H. Robins Company, Incorporated
Inventors:
Chandler R. Taylor, Jr., Albert D. Cale, Jr., Harold F. Stauffer, Jr.
Abstract: A method of treating animals to obtain muscle relaxation and/or to relieve anxiety is disclosed utilizing novel and known 3-aryloxy and 3-arylthioazetidinecarbonxamides having the formula: ##STR1## wherein Z is oxygen or sulfur; B is oxygen or sulfur; Ar is pyridyl or halo substituted pyridyl, phenyl or substituted phenyl; R.sup.1 and R.sup.2 are hydrogen, loweralkyl, aryl, allyl groups, propargyl, cycloalkyl, loweralkylcycloalkyl, cycloakylloweralkyl, arylloweralkyl and diloweralkylaminoalkyl, and R.sup.1 and R.sup.2 when taken together with the adjacent nitrogen atom may form a heterocyclic amine radical; R.sup.3 is hydrogen, loweralkyl, aryl or arylloweralkyl, and the geometrical isomers thereof and pharmaceutical salts thereof and hydrates thereof when they are possible.
Type:
Grant
Filed:
October 22, 1986
Date of Patent:
November 26, 1991
Assignee:
A. H. Robins Company Incorporated
Inventors:
Chandler R. Taylor, Jr., Albert D. Cale. Jr., David N. Johnson, Harold F. Stauffer. Jr.
Abstract: Novel compounds of the formula: ##STR1## Where R.sup.1 is loweralkyl and R.sup.2 and R.sup.3 are independently H, loweralkyl, aryl, or--NR.sup.2 R.sup.3 forms a heterocyclic group such as imidazole, morpholine, piperidine, or piperazine were found to exhibit cardiac arrhythmia correcting properties.
Abstract: A method of treating depression with 5-(aminoalkyl)-11-phenyl-5H-dibenzo[b,e][1,4]diazepines having the formula: ##STR1## wherein R.sup.1 and R.sup.2 are selected from hydrogen or methyl and X is selected from hydrogen, chlorine, bromine or fluorine is disclosed.